Lets compare the s-1s of two interesting digital health companies are going public in 2025
What are the hidden trade offs of fund size. When should founders be able to take money off the table?
This is a hot topic and I’ve heard plenty of arguments with both sides. Here’s my POV.
Employers tell me that preventative health is harder than ever
Omada got its start in 2011.
And no, ChatGPT is not the answer
Their impact on hormone health may be just what women in this life phase need
Sometimes a little less money is the right outcome
The age old question revisited, but with a 2025 spin
When to raise, how much & from whom?
Paid marketing is still useful - but competitive ad markets require more creativity
Part 1 in our founder's guide to financing your women's health startup
How healthcare founders should take lessons from teams navigating unpredictable events
An unexpected consequence of these blockbuster drugs
What is keeping employers up at night going into 2025? A conversation with Chris Michalak
